Carbonic Anhydrase-II Inhibition. What are the True Enzyme–Inhibitory Properties of the Sulfamide Cognate of Topiramate?
- 26 March 2008
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (8) , 2518-2521
Abstract
The marketed drug topiramate (1) is a moderate inhibitor of carbonic anhydrase-II (CA-II) (Ki or Kd = 0.3–0.6 µM), whereas sulfamide cognate 2 is a comparatively weak inhibitor (Ki or Kd = 25–650 µM). From an X-ray cocrystal structure of 2·CA-II, Winum et al. (J. Med. Chem. 2006, 49, 7024) proposed that an adverse steric interaction between the C8 methyl group in 2 and Ala-65 of CA-II is responsible for the diminished CA-II inhibitory potency of 2. We performed a straightforward test of this Ala-65 effect by synthesizing and examining ligand 3, which lacks the offending (pro-S or C8) methyl substituent in 2. We also prepared and evaluated related sulfamides 5, 7, and 9. In a CA-II inhibition assay (4-nitrophenyl acetate), the Ki for 3 was ∼300 µM, indicating very weak inhibition, close to that for 2 (4NPA, Ki = 340 µM). In a CA-II binding assay (ThermoFluor), the Kd for 3 was >57 µM, indicating very weak binding, lower than the affinity of 2 (Kd = 25 µM). Our results draw into question the proposed steric interaction between the C8 methyl of 2 and Ala-65 of CA-II.Keywords
This publication has 22 references indexed in Scilit:
- Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramateJournal of Enzyme Inhibition and Medicinal Chemistry, 2008
- Carbonic anhydrases as targets for medicinal chemistryBioorganic & Medicinal Chemistry, 2007
- Examination of Two Independent Kinetic Assays for Determining the Inhibition of Carbonic Anhydrases I and II: Structure?Activity Comparison of Sulfamates and SulfamidesChemical Biology & Drug Design, 2006
- Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding MeasurementsJournal of Medicinal Chemistry, 2006
- Comparison of Sulfamate and Sulfamide Groups for the Inhibition of Carbonic Anhydrase-II by Using Topiramate as a Structural PlatformJournal of Medicinal Chemistry, 2004
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Carbonic anhydrase inhibition in ophthalmology: Aqueous humor secretion and the development of sulfonamide inhibitors2000
- Carbonic anhydrase research: a clinical perspective, past and future2000
- Structure and mechanism of carbonic anhydrasePharmacology & Therapeutics, 1997
- The first anionic sulfonamide-binding zinc(II) complexes with a macrocyclic triamine: chemical verification of the sulfonamide inhibition of carbonic anhydraseJournal of the American Chemical Society, 1992